Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2575 of 3284 entries
View as:

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00460460 Org: User:
Start: 03/31/07 End: 08/31/07 Due: 08/31/08

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683

Phase: N/A Priority: Normal
NCT ID: NCT01419600 Org: User:
Start: 10/31/11 End: 05/31/12 Due: 05/31/13

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03528694 Org: User:
Start: 05/14/18 End: 09/30/25 Due: 09/30/26

Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01265654 Org: User:
Start: 01/31/11 End: 11/30/11 Due: 11/30/12

Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.

Phase: N/A Priority: Normal
NCT ID: NCT01525199 Org: User:
Start: 05/31/12 End: 11/30/13 Due: 11/30/14

Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)

Phase: N/A Priority: Normal
NCT ID: NCT00692146 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

Seroquel XR in the Long Term Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01202617 Org: User:
Start: 09/30/10 End: 10/31/11 Due: 10/31/12

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00255255 Org: User:
Start: 11/30/05 End: 06/30/07 Due: 06/30/08

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01888575 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

Phase IV O2 Consumption Study in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02533505 Org: User:
Start: 08/25/15 End: 08/12/16 Due: 08/12/17

Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006

Phase: N/A Priority: Normal
NCT ID: NCT00695357 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06311760 Org: User:
Start: 04/09/24 End: 02/20/25 Due: 02/20/26

LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT04889404 Org: User:
Start: 05/22/21 End: 02/06/25 Due: 02/06/26

Iressa as Second Line Therapy in Advanced NSCLC-Asia

Phase: N/A Priority: Normal
NCT ID: NCT00478049 Org: User:
Start: 09/30/05 End: 02/28/09 Due: 02/28/10

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

Phase: N/A Priority: Normal
NCT ID: NCT00314782 Org: User:
Start: 03/31/06 End: 03/31/09 Due: 03/31/10

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Phase: N/A Priority: Normal
NCT ID: NCT00410592 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00672581 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

Phase: N/A Priority: Normal
NCT ID: NCT00688675 Org: User:
Start: 02/29/08 End: 08/31/08 Due: 08/31/09

Effectiveness of Anti-Psychotic in GPs Setting

Phase: N/A Priority: Normal
NCT ID: NCT00543088 Org: User:
Start: 01/31/07 End: 06/30/08 Due: 06/30/09

A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry

Phase: N/A Priority: Normal
NCT ID: NCT05351047 Org: User:
Start: 04/04/22 End: 07/06/23 Due: 07/06/24

AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04507256 Org: User:
Start: 08/18/20 End: 10/19/21 Due: 10/19/22

Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

Phase: N/A Priority: Normal
NCT ID: NCT00642096 Org: User:
Start: 06/30/03 End: 07/31/04 Due: 07/31/05

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT02588859 Org: User:
Start: 10/30/15 End: 12/26/16 Due: 12/26/17

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00774553 Org: User:
Start: 10/31/08 End: 01/31/10 Due: 01/31/11

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT00595517 Org: User:
Start: 10/31/07 End: 09/30/09 Due: 09/30/10